Bayer lifted by likely new trial in $250 million weedkiller case

The prospect of a fresh trial that could overturn $250 million damages against Bayer’s Monsanto unit lifted the German company’s shares, after an August ruling that it failed to warn users of the alleged cancer risks of its weedkillers.

Leave a Reply

Your email address will not be published. Required fields are marked *